Dendritic cell specific targeting of MyD88 signalling pathways in vivo. Issue 1 (16th December 2014)

• Record Type: Journal Article
• Authors: Arnold‐Schrauf, Catharina; Berod, Luciana; Sparwasser, Tim
• Is Part Of: European journal of immunology. Volume 45:Issue 1(2015)
• Page Start: 32
• Page End: 39
• Publication Date: 2014-12-16
• Subjects: Immunology -- Periodicals; 616.079
• DOI: 10.1002/eji.201444747
• Languages: English
• ISSNs: 0014-2980

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Dendritic cells (DCs) are key regulators of both innate and adaptive immunity. During infection, DCs recognise pathogen‐associated molecular patterns (PAMPs) via pattern recognition receptors (PRRs) including the Toll‐like receptor (TLR) family. TLRs mainly signal via the adaptor protein MyD88. This signalling pathway is required for immune protection during many infections, which are lethal in the absence of MyD88. However, the cell type specific importance of this pathway during both innate and adaptive immune responses against pathogens in vivo remains ill‐defined. We discuss recent findings from conditional KO or gain‐of‐function mouse models targeting TLR/MyD88 signalling pathways in DCs and other myeloid cells during infection. While the general assumption that MyD88‐dependent recognition by DCs is essential for inducing protective immunity holds true in some instances, the results surprisingly indicate a much more complex context‐dependent requirement for this pathway in DCs and other myeloid or lymphoid cell‐types in vivo. Furthermore, we highlight the advantages of Cre‐mediated DC targeting approaches and their possible limitations. We also present future perspectives on the development of new genetic mouse models to target distinct DC subsets in vivo. Such models will serve to understand the functional heterogeneity of DCs in vivo.</p> </abstract>